Skip to main content
Fig. 1 | BMC Gastroenterology

Fig. 1

From: Direct oral anticoagulants increase bleeding risk after endoscopic sphincterotomy: a retrospective study

Fig. 1

Study population. Of the 676 patients treated with EST from May 2016 to August 2019, 152 patients were excluded based on the exclusion criteria (this study enrolled patients undergoing EST who were treated with either a DOAC prior to the EST or no antithrombotic agents). The exclusion criterion was the use of warfarin or antiplatelet therapy only. EST, endoscopic sphincterotomy; DOAC, direct oral anticoagulants

Back to article page